Innovative Research, Inc. Acquires Molecular Innovations, Inc.

Posted by Adam Awdish on

Novi, MI, October 1, 2021 - Innovative Research, Inc. has finalized its agreement to acquire Molecular Innovations, Inc.  “These two companies have been strategic partners for the past twenty years, it only makes sense they merge and improve future collaboration and operations,” says Carl Rosenblum, Director of Customer Support at Innovative Research.  “As we went through this process it became clearer what we were gaining as a total organization by joining Innovative Research,” said Duane Day, President and Owner of Molecular Innovations, Inc.


This combination of resources will allow Innovative Research to leverage the thirty years of high-quality production and expertise in coagulation and thrombolysis while identifying new areas of product development and investment to meet customer need. Headquarters will be maintained in Novi, MI and Innovative Research will continue to provide reliable reagents to clients both domestic and International.

If you have an unfulfilled Molecular Innovations Sales Order, you will be notified with updated information on October 4, 2021. Should your original PO need revised for proper fulfillment, your assistance in doing so is appreciated.  Please direct any inquiries to Carl Rosenblum, 248-896-0145, ext. 102.


Share this post


Related Posts

Looking Ahead: Exciting Innovations and Opportunities in 2025
As we begin 2025, our CEO, Donna J. Schelby, shares a message reflecting on 2024’s achi...
Read the Article
Interview with Shanon Turnbaugh: Innovative Research’s New Head of Molecular Biology
Innovative Research is delighted to welcome Shanon Turnbaugh as Head of our Molecular B...
Read the Article
Now Featuring: Reduced Prices on Blood-Derived Human Plasma
At Innovative Research, we're committed to supporting your research with the highest qu...
Read the Article

← Older Post Newer Post →

×